Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernard A Fox

Showing results (71-80 of 158) with videos related to

Pageof 16
Sort By:
Journal for Immunotherapy of Cancer|May 29, 2020
Heterodimeric IL-15 delays tumor growth and promotes intratumoral CTL and dendritic cell accumulation by a cytokine network involving XCL1, IFN-γ, CXCL9 and CXCL10Cristina Bergamaschi, Hrishikesh Pandit, Bethany A Nagy, et al.
European Journal of Cancer (Oxford, England : 1990)|July 10, 2025
Approaches to overcome the current treatment plateau in immunotherapyAnna Maria Di Giacomo, Renzo Canetta, John Connolly, et al.
Onkologie|March 4, 2006
Immunotherapy of lung cancer: an updateDominik Rüttinger, Hauke Winter, Natasja K van den Engel, et al.
Journal of Translational Medicine|April 22, 2022
The "Great Debate" at Immunotherapy Bridge 2021, December 1st-2nd, 2021Paolo A Ascierto, Lisa H Butterfield, Olivera J Finn, et al.
Oral Oncology|November 29, 2015
OX40 signaling in head and neck squamous cell carcinoma: Overcoming immunosuppression in the tumor microenvironmentR Bryan Bell, Rom S Leidner, Marka R Crittenden, et al.
Journal of Translational Medicine|September 18, 2007
Adjuvant therapeutic vaccination in patients with non-small cell lung cancer made lymphopenic and reconstituted with autologous PBMC: first clinical experience and evidence of an immune responseDominik Rüttinger, Natasja K van den Engel, Hauke Winter, et al.
European Journal of Cancer (Oxford, England : 1990)|April 1, 2025
Perspectives on the role of "-Omics" in predicting response to immunotherapyAnna Maria Di Giacomo, Sumit Subudhi, Wim Vos, et al.
Immunology|February 27, 2003
Tumour-induced polarization of tumour vaccine-draining lymph node T cells to a type 1 cytokine profile predicts inherent strong immunogenicity of the tumour and correlates with therapeutic efficacy in adoptive transfer studiesHauke Winter, Hong-Ming Hu, Christian H Poehlein, et al.
Journal of Translational Medicine|June 15, 2006
Combined IL-21 and low-dose IL-2 therapy induces anti-tumor immunity and long-term curative effects in a murine melanoma tumor modelHong He, Preya Wisner, Guojun Yang, et al.
Oncoimmunology|December 8, 2018
Autophagosome-based strategy to monitor apparent tumor-specific CD8 T cells in patients with prostate cancerRieneke van de Ven, Traci L Hilton, Hong-Ming Hu, et al.
Pageof 16

Showing results (71-80 of 158) with videos related to

Sort By:
Pageof 16
Journal for Immunotherapy of Cancer|May 29, 2020
Heterodimeric IL-15 delays tumor growth and promotes intratumoral CTL and dendritic cell accumulation by a cytokine network involving XCL1, IFN-γ, CXCL9 and CXCL10Cristina Bergamaschi, Hrishikesh Pandit, Bethany A Nagy, et al.
European Journal of Cancer (Oxford, England : 1990)|July 10, 2025
Approaches to overcome the current treatment plateau in immunotherapyAnna Maria Di Giacomo, Renzo Canetta, John Connolly, et al.
Onkologie|March 4, 2006
Immunotherapy of lung cancer: an updateDominik Rüttinger, Hauke Winter, Natasja K van den Engel, et al.
Journal of Translational Medicine|April 22, 2022
The "Great Debate" at Immunotherapy Bridge 2021, December 1st-2nd, 2021Paolo A Ascierto, Lisa H Butterfield, Olivera J Finn, et al.
Oral Oncology|November 29, 2015
OX40 signaling in head and neck squamous cell carcinoma: Overcoming immunosuppression in the tumor microenvironmentR Bryan Bell, Rom S Leidner, Marka R Crittenden, et al.
Journal of Translational Medicine|September 18, 2007
Adjuvant therapeutic vaccination in patients with non-small cell lung cancer made lymphopenic and reconstituted with autologous PBMC: first clinical experience and evidence of an immune responseDominik Rüttinger, Natasja K van den Engel, Hauke Winter, et al.
European Journal of Cancer (Oxford, England : 1990)|April 1, 2025
Perspectives on the role of "-Omics" in predicting response to immunotherapyAnna Maria Di Giacomo, Sumit Subudhi, Wim Vos, et al.
Immunology|February 27, 2003
Tumour-induced polarization of tumour vaccine-draining lymph node T cells to a type 1 cytokine profile predicts inherent strong immunogenicity of the tumour and correlates with therapeutic efficacy in adoptive transfer studiesHauke Winter, Hong-Ming Hu, Christian H Poehlein, et al.
Journal of Translational Medicine|June 15, 2006
Combined IL-21 and low-dose IL-2 therapy induces anti-tumor immunity and long-term curative effects in a murine melanoma tumor modelHong He, Preya Wisner, Guojun Yang, et al.
Oncoimmunology|December 8, 2018
Autophagosome-based strategy to monitor apparent tumor-specific CD8 T cells in patients with prostate cancerRieneke van de Ven, Traci L Hilton, Hong-Ming Hu, et al.
Pageof 16